Status:

COMPLETED

Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry

Lead Sponsor:

ResMed

Conditions:

Congestive Heart Failure

Left Ventricular Systolic Dysfunction

Eligibility:

All Genders

18+ years

Brief Summary

Objective target of the registry is to investigate the prevalence of SDB as well as the clinical characteristics of patients with and without SDB as well as the predominant type of sdb. For this purp...

Detailed Description

Despite recent advances in pharmacological treatment, congestive heart failure (CHF) continues to cause debilitating symptoms, frequent hospital admissions and a high mortality. Despite of therapy wit...

Eligibility Criteria

Inclusion

  • Patients must be over 18
  • Chronic heart failure (at least 12 weeks since diagnosis) according to the current applicable guidelines
  • Left ventricular systolic dysfunction (LVEF ≤ 45% by imaging method such as echocardiography, radionuclide angiography, left ventriculography, or cardiac magnetic resonance imaging) documented less than 12 weeks
  • NYHA class III or IV at the time of inclusion or NYHA class II with at least one hospitalisation for HF in the last 24 months
  • Patient is able to fully understand study information and signed informed consent

Exclusion

  • Life expectancy \< 1 year for diseases unrelated to chronic HF
  • Cardiac surgery, Percutaneous coronary intervention (PCI), Myocardial Infarction (MI) or unstable angina within 6 months
  • CRT-implantation (either CRT-D or CRT-P) scheduled or within 6 months
  • Transient ischemic attack (TIA) or Stroke within 3 months
  • Hemodynamically significant uncorrected primary valvular heart disease, obstructive or regurgitant, or any valvular disease expected to lead to surgery
  • Acute myocarditis/pericarditis within 6 months
  • Current CPAP or bilevel therapy

Key Trial Info

Start Date :

November 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2013

Estimated Enrollment :

6876 Patients enrolled

Trial Details

Trial ID

NCT01500759

Start Date

November 1 2007

End Date

May 1 2013

Last Update

July 9 2020

Active Locations (199)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 50 (199 locations)

1

Westmead Hospital

Westmead, New South Wales, Australia, 2145

2

Rivercity Private Hospital

Auchenflower, Queensland, Australia, 4066

3

Royal Adelaide Hospital

Adelaide, South Australia, Australia, 5000

4

Baker IDI Heart and Diabetes Institute

Melbourne, Victoria, Australia, 3004